Hyderabad paediatrician Dr. Sivaranjani Santosh, who advocated for clearer ORS labelling, receives legal notice from companies linked to Kenvue and Johnson & Johnson.
India’s doctor from multiple associations are uniting to support a Hyderabad based paediatrician who has dedicated years to protecting children’s health. Dr. Sivaranjani Santosh a practising paediatrician with nearly two decades of experience is now at the centre of a debate about corporate accountability, public health advocacy and the right of medical professionals to speak out on patient safety.
This isn’t just another news story it’s a powerful reminder for every parent, caregiver and healthcare professional about how everyday product choices can impact our little ones during vulnerable moments like dehydration from diarrhoea or vomiting. Let’s break down what happened, why it matters and what you can learn as a parent navigating the crowded pharmacy aisles.
Dr. Sivaranjani Santosh’s 8 Year Fight for Clarity
Dr. Sivaranjani Santosh didn’t set out to take on big brands. As a practising paediatrician in Hyderabad, she simply noticed a troubling pattern in her clinic: children arriving more dehydrated or with prolonged symptoms after parents gave them certain popular electrolyte drinks thinking they were proper ORS.
Starting around 2016–2018, she began raising awareness through social media, parent education sessions and advocacy with regulators. She highlighted how misleading labelling and shelf placement were confusing caregivers. Her campaign wasn’t about attacking any single company it was about science based clarity so parents could make informed choices during medical emergencies.
Her efforts gained momentum with support from other doctors, Women Paediatricians Forum, parents and influencers. In 2024, she even filed a PIL to push for stricter rules. Turning point came in October 2025 when the Food Safety and Standards Authority of India (FSSAI) issued clear directives: no food or beverage brand can use the term “ORS” (or variations like prefixes/suffixes in brand names) unless the product strictly matches the WHO approved formula. This landmark order aimed to eliminate confusion and protect children nationwide.
It was a hard won victory for public health one that Dr. Santosh and many in the medical community celebrated as a step toward transparent labelling.
The Latest Development: Legal Notice Sparks Outrage
Fast forward to mid March 2026. Dr. Santosh received a cease and desist legal notice dated March 16 from companies linked to Johnson & Johnson Health Equity and Kenvue (the consumer health division). The notice reportedly accused her of making “false,misleading, disparaging and defamatory” statements on social media about their products (including the earlier ORSL and its rebranded version). It demanded she remove posts and stop commenting claiming her advocacy was for personal gain or followers.In a video response shared widely, Dr. Santosh stood firm, stating that her position is fully backed by the FSSAI orders of October 2025 and that her legal team would handle the matter. She emphasized that her comments were rooted in clinical observations and regulatory facts not personal vendetta.
Doctors Stand United: “This Is Intimidation”
The medical fraternity has responded swiftly and strongly. The Telangana Senior Resident Doctors Association (T-SRDA) warned that if the notice isn’t withdrawn promptly, they will consider collective action in coordination with other medical bodies. The Federation of All India Medical Associations (FAIMA) and the Healthcare Reforms Doctors Association (HRDA) have also issued statements condemning the move as an attempt to silence evidence based public health advocacy.
They argue that doctors have a professional and ethical duty to share scientific concerns that protect patients especially children. Suppressing such voices they say sets a dangerous precedent and could discourage other professionals from speaking up on issues that affect public welfare.
Social media has lit up with support from parents, public health experts and fellow doctors many praising Dr. Santosh’s courage and calling for continued focus on child safety over commercial interests.
Dr. Santosh’s journey shows that one doctor’s persistent voice backed by evidence, can drive nationwide change. It also reminds us that advocacy in healthcare isn’t always comfortable but it’s essential.
What Happens Next?
The story is still developing. As of March 25, 2026, the legal notice is being processed and medical associations are watching closely. Many hope for a quick resolution that upholds doctors’ right to evidence based discussion while encouraging companies to focus on clear non confusing marketing.
In the meantime, this episode reinforces the importance of staying informed. As parents, we owe it to our children to read labels, ask questions, and support professionals who prioritize safety over silence.
The Rajasthan Government Health Scheme (RGHS) has been a lifeline for lakhs of state government employees, pensioners and their families but right now cashless medicine distribution at private OPD pharmacies has been suspended due to massive pending payments
A 45 year old patient named Biswajit Samanta from Nimta reportedly collapsed and died at RG Kar Medical College and Hospital after his family claims he was forced to walk to a distant toilet while in critical condition. No stretcher, wheelchair or assistance was provided despite repeated requests.
A landmark decision that transform medical education and public healthcare in Andhra Pradesh, State government has given the green light to recruit 520 fresh staff positions for the new Government Medical College at Piduguralla. This move comes as the state gears up to welcome its first batch of MBBS students at the college from the 2026-27 academic session.
